| For: | Miller HC, Kidd M, Modlin IM, Cohen P, Dina R, Drymousis P, Vlavianos P, Klöppel G, Frilling A. Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome. World J Gastrointest Surg 2015; 7(4): 60-66 [PMID: 25914784 DOI: 10.4240/wjgs.v7.i4.60] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v7/i4/60.htm |
| Number | Citing Articles |
| 1 |
Derek K. Smith, Lance Kates, Steffen Durinck, Nisha Patel, Eric W. Stawiski, Noelyn Kljavin, Oded Foreman, Bence Sipos, Mark J. Solloway, Bernard B. Allan, Andrew S. Peterson. Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation. Cell Reports Medicine 2020; 1(5) doi: 10.1016/j.xcrm.2020.100058
|
| 2 |
Nicolai J. Wewer Albrechtsen, Kristine Færch, Troels M. Jensen, Daniel R. Witte, Jens Pedersen, Yuvaraj Mahendran, Anna E. Jonsson, Katrine D. Galsgaard, Marie Winther-Sørensen, Signe S. Torekov, Torsten Lauritzen, Oluf Pedersen, Filip K. Knop, Torben Hansen, Marit E. Jørgensen, Dorte Vistisen, Jens J. Holst. Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids. Diabetologia 2018; 61(3) doi: 10.1007/s00125-017-4535-5
|
| 3 |
Qiaofeng Liu, Guangyao Lin, Yan Chen, Wenbo Feng, Yingna Xu, Jianjun Lyu, Dehua Yang, Ming-Wei Wang. Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver–α-cell axis. Bioscience Reports 2021; 41(6) doi: 10.1042/BSR20210758
|
| 4 |
Jelka Kuiper, Wouter W de Herder, Yassine Ben Brahim, Marie-Louise F van Velthuysen, Lodewijk A A Brosens, Richard A Feelders, Janneke G Langendonk, Ronald van Marion, Esther Korpershoek, Günter Klöppel, Anja Wagner, Johannes Hofland. Familial Mahvash disease with metastatic pancreatic NET and MEN1 mutations. Endocrine-Related Cancer 2025; 32(6) doi: 10.1530/ERC-25-0087
|
| 5 |
Nicolai J Wewer Albrechtsen, Jens Pedersen, Katrine D Galsgaard, Marie Winther-Sørensen, Malte P Suppli, Lina Janah, Jesper Gromada, Hendrik Vilstrup, Filip K Knop, Jens J Holst. The Liver–α-Cell Axis and Type 2 Diabetes. Endocrine Reviews 2019; 40(5) doi: 10.1210/er.2018-00251
|
| 6 |
Xujun Song, Suli Zheng, Gang Yang, Guangbing Xiong, Zhe Cao, Mengyu Feng, Taiping Zhang, Yupei Zhao. Glucagonoma and the glucagonoma syndrome (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7703
|
| 7 |
Kai Duan, Ozgur Mete. Hereditary Endocrine Tumor Syndromes: The Clinical and Predictive Role of Molecular Histopathology. AJSP: Reviews and Reports 2017; 22(5) doi: 10.1097/PCR.0000000000000206
|
| 8 |
Anne Couvelard. Encyclopedia of Pathology. Encyclopedia of Pathology 2020; doi: 10.1007/978-3-319-28845-1_5129-1
|
| 9 |
Qi Kang, Jihong Zheng, Jianxin Jia, Ying Xu, Xuanxuan Bai, Xinhua Chen, Xiao-Kun Zhang, F. Susan Wong, Chao Zhang, Mingyu Li. Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish. Journal of Biological Chemistry 2022; 298(12) doi: 10.1016/j.jbc.2022.102665
|
| 10 |
Fiona Campbell, Caroline S. Verbeke. Pathology of the Pancreas. 2021; doi: 10.1007/978-3-030-49848-1_20
|
| 11 |
Max B. Albers, Jerena Manoharan, Detlef K. Bartsch. Viszeral- und Allgemeinchirurgie. Springer Reference Medizin 2022; doi: 10.1007/978-3-662-61724-3_45-1
|
| 12 |
Ozgur Mete, Fady Hannah-Shmouni, Raymond Kim, Constantine A. Stratakis. The Spectrum of Neuroendocrine Neoplasia. 2021; doi: 10.1007/978-3-030-54391-4_18
|
| 13 |
Max B. Albers, Jerena Manoharan, Detlef K. Bartsch. Endokrine Chirurgie. Springer Reference Medizin 2023; doi: 10.1007/978-3-662-63317-5_45
|
| 14 |
E. Danielle Dean, Mingyu Li, Nripesh Prasad, Scott N. Wisniewski, Alison Von Deylen, Jason Spaeth, Lisette Maddison, Anthony Botros, Leslie R. Sedgeman, Nadejda Bozadjieva, Olga Ilkayeva, Anastasia Coldren, Greg Poffenberger, Alena Shostak, Michael C. Semich, Kristie I. Aamodt, Neil Phillips, Hai Yan, Ernesto Bernal-Mizrachi, Jackie D. Corbin, Kasey C. Vickers, Shawn E. Levy, Chunhua Dai, Christopher Newgard, Wei Gu, Roland Stein, Wenbiao Chen, Alvin C. Powers. Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation. Cell Metabolism 2017; 25(6) doi: 10.1016/j.cmet.2017.05.011
|
| 15 |
Ozgur Mete, Runjan Chetty. Pancreatic endocrine neoplasia: familial syndromes. Diagnostic Histopathology 2017; 23(8) doi: 10.1016/j.mpdhp.2017.06.005
|
| 16 |
Jinrang Kim, Giselle Dominguez Gutierrez, Yurong Xin, Katie Cavino, Biin Sung, Bence Sipos, Guenter Kloeppel, Jesper Gromada, Haruka Okamoto. Increased SLC38A4 Amino Acid Transporter Expression in Human Pancreatic α-Cells After Glucagon Receptor Inhibition. Endocrinology 2019; 160(5) doi: 10.1210/en.2019-00022
|
| 17 |
Megan E. Capozzi, David A. D’Alessio, Jonathan E. Campbell. The past, present, and future physiology and pharmacology of glucagon. Cell Metabolism 2022; 34(11) doi: 10.1016/j.cmet.2022.10.001
|
| 18 |
Yoshitaka Hayashi, Yusuke Seino. Regulation of amino acid metabolism and α‐cell proliferation by glucagon. Journal of Diabetes Investigation 2018; 9(3) doi: 10.1111/jdi.12797
|
| 19 |
Michele Bevere, Anastasios Gkountakos, Filippo Maria Martelli, Aldo Scarpa, Claudio Luchini, Michele Simbolo. An Insight on Functioning Pancreatic Neuroendocrine Neoplasms. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020303
|
| 20 |
Kehan Bao, Jason Berger, Erqian Na, Qi Su, Gabor Halasz, Mark Sleeman, Haruka Okamoto. Hepatic PKA Mediates Liver and Pancreatic α-Cell Cross Talk. Diabetes 2025; 74(6) doi: 10.2337/db24-0958
|
| 21 |
Anne Couvelard. Endocrine Pathology. Encyclopedia of Pathology 2022; doi: 10.1007/978-3-030-62345-6_5129
|
| 22 |
Matti L Gild, Venessa Tsang, Jaswinder Samra, Roderick J Clifton-Bligh, Lyndal Tacon, Anthony J Gill. Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association. The Journal of Clinical Endocrinology & Metabolism 2018; 103(9) doi: 10.1210/jc.2018-01074
|